<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372157">
  <stage>Registered</stage>
  <submitdate>13/01/2017</submitdate>
  <approvaldate>1/05/2017</approvaldate>
  <actrnumber>ACTRN12617000627358</actrnumber>
  <trial_identification>
    <studytitle>Partial nephrectomy in renal cell carcinoma stage pT2: A retrospective outcome analysis and historical comparison.</studytitle>
    <scientifictitle>Partial nephrectomy in renal cell carcinoma stage pT2: A retrospective outcome analysis and historical comparison.</scientifictitle>
    <utrn>U1111-1191-5973</utrn>
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Renal cell carcinoma stage T2</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Kidney</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A retrospective review of our prospectively entered nephrectomy registry (Departement of Urology, University of Bern) was performed between 2015-2016. 25 patients were identified who underwent partial nephrectomy for renal cell carcinoma stage pT2 at our institution between 1979 and 2014. Data were analyzed regarding perioperative, oncological and overall outcomes.</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Overall survival after partial nephrectomy assessed by review of medical records.</outcome>
      <timepoint>After the median follow-up of 21 month.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Postoperative complication rate by review of medical records and classified according to the Clavien-Dindo classification.</outcome>
      <timepoint>Within 30 days after surgery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cancer-specific outcome after partial nephrectomy assesed by review of medical records.  Cancer-specific outcome was grouped as cancer-free survival, distant or local recurrence or death from cancer.</outcome>
      <timepoint>After the median follow-up of 21 month.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Comparison between pre- and postoperative renal function by comparing pre- with postoperative serume creatinine. The data was collected through review of medical records.</outcome>
      <timepoint>Postoperative renal function was assessed before discharge from the hospital.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Tumor characteristics.</outcome>
      <timepoint>According to the histopathological report.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with renal cell carcinoma stage pT2 that underwent a partial nephrectomy.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>None</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>All patients that underwent partial nephrectomy and met the inclusion criteria were included.
The SPSS software package version 23.0. (IBM Corp., Somers, NY, USA) was used for all statistical analyses. Comparisons between pre- and postoperative renal function groups were performed using Paired T-test. Overall and cancer-specific survival were estimated using the Kaplan-Meier method.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Retrospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>1/01/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate>30/06/2016</actualenddate>
    <samplesize>50</samplesize>
    <actualsamplesize>25</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>29/07/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Bern</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Urologische Universitaetsklinik, Inselspital Bern</primarysponsorname>
    <primarysponsoraddress>Urologische Universitaetsklinik, Inselspital
Anna Seiler-Haus
Freiburgstrasse 5
3010 Bern</primarysponsoraddress>
    <primarysponsorcountry>Switzerland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Bern, Department of Urology</fundingname>
      <fundingaddress>Urologische Universitaetsklinik, Inselspital
Anna Seiler-Haus
Freiburgstrasse 5
3010 Bern</fundingaddress>
      <fundingcountry>Switzerland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the present study was to examine our institutional experience in a cohort of patients treated with partial nephrectomy for renal cell carcinoma stage pT2. We analyzed 25 patients treated by partial nephrectomy regarding the overall, cancer-specific and perioperative outcome. The results were compared with those of recently published studies on the same topic.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Swissethics - Ethikkommission fuer Forschung am Menschen</ethicname>
      <ethicaddress>Haus der Akademien
Laupenstrasse 7
CH-3008 Bern</ethicaddress>
      <ethicapprovaldate>12/12/2016</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>4/10/2016</ethicsubmitdate>
      <ethiccountry>Switzerland</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Prof Dr. med. George Niklaus Thalmann</name>
      <address>Universitaetsklinik fuer Urologie
Anna Seiler Haus
3010 Bern</address>
      <phone>+41 31 362 21 11</phone>
      <fax />
      <email>george.thalmann@insel.ch</email>
      <country>Switzerland</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Prof Dr. med. George Niklaus Thalmann</name>
      <address>Universitaetsklinik fuer Urologie
Anna Seiler Haus
3010 Bern</address>
      <phone>+41 31 362 21 11</phone>
      <fax />
      <email>george.thalmann@insel.ch</email>
      <country>Switzerland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Prof Dr. med. George Niklaus Thalmann</name>
      <address>Universitaetsklinik fuer Urologie
Anna Seiler Haus
3010 Bern</address>
      <phone>+41 31 362 21 11</phone>
      <fax />
      <email>george.thalmann@insel.ch</email>
      <country>Switzerland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Urs Graf</name>
      <address>Scheuermattweg 8
3007 Bern</address>
      <phone />
      <fax />
      <email />
      <country>Switzerland</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>